Background/Aim: α-Thalassemia (α-thal) is a widespread genetic disorder throughout the world caused primarily by reduced synthesis of the α-globin chains, and it has been found at a high incidence in Turkey. Our aim in this study was to determine the frequency and molecular properties of α-thal in Adana, Turkey. Material and Methods: A total of 3,000 individuals comprising premarital couples or patients with anemia were screened between 2007 and 2008. Hematological parameters were analyzed using an automatic cell counter, and to detect the carriers of hemoglobin variants, high-performance liquid chromatography was used. Molecular screening of the α-globin gene was carried out by an Alpha-Globin StripAssay® which is based on multiplex PCR for specific amplification. Results: We have identified 225 cases with α-thal and found that the prevalence of α-thal is 7.5% in this area. In molecular analyses, the α-thal gene mutations α3.7, α4.2, --MED, --20.5, αPA-2α, αααanti-3.7, and αPA-1α were detected. Conclusion: Our results showed that the α-thal mutations represent a great heterogeneity and that the -α3.7 deletion has the highest frequency in Adana.

Keywords:
-α3.7 deletion, α-Thalassemia, Frequency, α-thalassemia, Heterogeneity, Molecular properties, α-thalassemia, Mutations
1.
Sengchanh S, Sanguansermsri T, Horst D, Horst J, Flatz G: High frequency of alpha-thalassemia in the So ethnic group of South Laos. Acta Haematol 2005;114:164–166.
2.
Weatherall DJ: Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001;2:245–255.
3.
Weatherall DJ, Clegg JB: Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001;79:704–712.
4.
Chui DH, Fucharoen S, Chan V: Hemoglobin H disease: not necessarily a benign disorder. Blood 2003;101:791–800.
5.
Sae-ung N, Fucharoen G, Sanchaisuriya K, Fucharoen S: Alpha(0)-thalassemia and related disorders in northeast Thailand: a molecular and hematological characterization. Acta Haematol 2007;117:78–82.
6.
Oron-Karni V, Filon D, Shifrin Y, Fried E, Pogrebijsky G, Oppenheim A, Rund D: Diversity of alpha-globin mutations and clinical presentation of alpha-thalassemia in Israel. Am J Hematol 2000;65:196–203.
7.
Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P: Human alpha-thalassemia syndromes: detection of molecular defects. Am J Hematol 1996;53:81–91.
8.
Puehringer H, Najmabadi H, Law HY, Krugluger W, Viprakasit V, Pissard S, Baysal E, Taher A, Farra C, Al-Ali A, Al-Ateeq S, Oberkanins C: Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common alpha-thalassemia point mutations and deletions. Clin Chem Lab Med 2007;45:605–610.
9.
Curuk MA, Genç A, Huseynova P, Zeren F, Aksoy A: Genotypes of alpha thalassemia and Hb H disease in Çukurova. Turkiye Klinikleri J Pediatr Sci 2007;3:17–23.
10.
Danquah I, Mockenhaupt FP: Alpha(+)-thalassaemia and malarial anaemia. Trends Parasitol 2008;24:479–481.
11.
Oner C, Gürgey A, Oner R, Balkan H, Gümrük F, Baysal E, Altay C: The molecular basis of Hb H disease in Turkey. Hemoglobin 1997;21:41–51.
12.
Lukens JN: The abnormal hemoglobins: general priciples; in Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (eds): Wintrobe’s Clinical Hematology, ed 10. Giza, Mass Publishing Co., 1999, pp 1329–1345.
13.
Al-Allawi NA, Badi AI, Imanian H, Nikzat N, Jubrael JM, Najmabadi H: Molecular characterization of alpha-thalassemia in the Dohuk region of Iraq. Hemoglobin 2009;33:37–44.
14.
Rund D, Filon D, Jackson N, Asher N, Oron-Karni V, Sacha T, Czekalska S, Oppenheim A: An unexpectedly high frequency of heterozygosity for alpha-thalassemia in Ashkenazi Jews. Blood Cells Mol Dis 2004;33:1–3.
15.
Ayala S, Colomer D, Aymerich M, Pujades A, Vives-Corrons JL: Nondeletional alpha-thalassemia: first description of alpha Hph alpha and alpha Nco alpha mutations in a Spanish population. Am J Hematol 1996;52:144–149.
16.
Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S: alpha-thalassaemia in Tunisia: some epidemiological and molecular data. J Genet 2008;87:229–234.
17.
Di Bella C, Salpietro C, La Rosa M, Cuppari C, Piraino B, Cutri MR, Rigoli L: Identification of alpha-thalassemia mutations in subjects from Eastern Sicily (Italy) with abnormal hematological indices and normal Hb A2. Ann Hematol 2006;85:829–831.
18.
Charoenkwan P, Taweephon R, Sae-Tung R, Thanarattanakorn P, Sanguansermsri T: Molecular and clinical features of Hb H disease in northern Thailand. Hemoglobin 2005;29:133–140.
19.
Leung KY, Liao C, Li QM, Ma SY, Tang MH, Lee CP, Chan V, Lam YH: A new strategy for prenatal diagnosis of homozygous alpha-thalassemia. Ultrasound Obstet Gynecol 2006;28:173–177.
20.
Leung WC, Leung KY, Lau ET, Tang MH, Chan V: Alpha-thalassaemia. Semin Fetal Neonatal Med 2008;13:215–222.
21.
El-Kalla S, Baysal E: alpha-thalassemia in the United Arab Emirates. Acta Haematol 1998;100:49–53.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.